Interleukin-2 and interleukin-6 gene promoter polymorphisms, and early failure of dental implants

Implant Dentistry

Volumn 14, Issue 4, 2005, Pages 391-398

  Campos, Maria Isabela Guimarães ^a   Godoy Dos Santos, Maria Cristina Leme ^a   Trevilatto, Paula Cristina ^b   Scarel Caminaga, Raquel Mantuaneli ^c   Bezerra, Fabio Jose ^d   Line, Sergio Roberto Peres ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d Departamento de Morfologia ^*

Author keywords

Gene polymorphism; Implant failure; Interleukin 2; Interleukin 6; Osseointegration

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 6;

ADULT; ARTICLE; CASE CONTROL STUDY; DENTAL SURGERY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; PROMOTER REGION; TIME; TOOTH IMPLANTATION;

ADULT; CASE-CONTROL STUDIES; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; FEMALE; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TIME FACTORS;

EID: 33644874155     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000188470.54417.98     Document Type: Article

References (62)

1. Parfitt AM. The two faces of growth: Benefits and risks to bone integrity. Osfeoporos Int. 1994;4:382-398.
2. Tatakis DN. Interleukin-1 and bone metabolism: A review. J Periodontol. 1993;64:416-431.
3. Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol. 1998:113:28-32.
4. Ries WL, Seeds MC, Key LL. Interleukin-2 stimulates osteoclastic activity: Increased acid production and radioactive calcium release. J Periodontol Res. 1989:24:242-246.
5. Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985: 82:5490-5494.
6. May LT, Ghrayeb J, Santhanam U, et al. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem. 1988;263:7760-7766.
7. Mantovani L, Mertelsmann R, Henschler R. Regulation of gene expression of macrophage-colony stimulating factor in human fibroblasts by the acute phase response mediators interleukin (IL)-1 beta, tumor necrosis factor-alpha and IL-6. FEBS Lett. 1998;429:426.
8. Podor TJ, Jirik FR, Loskutoff DJ, et al. Human endothelial cells produce IL-6. Lack of responses to exogenous IL-6. Ann N Y Acad Sci. 1989;557:374-385.
9. Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation. 2001;72:1444-1450.
10. Plaut M, Pierce JH, Watson CJ, et al. Mast cell lines produce Iymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 1989; 339:64-67.
11. Lotz M, Jirik F, Kabouridis P, et al. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T Ilymphocytes. J Exp Med. 1988; 167:1253-1258.
12. Fridman WH, Michon J. Patho-physiology of cytokines. Leuk Res. 1990; 14:675-677.
13. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990; 145:3297-3303.
14. Adell R, Eriksson B, Lekholm U, et al. Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants. 1990;5:347-359.
15. Listgarten MA, Lang NP, Schroeder HE, et al. Periodontal tissues and their counterparts around endosseous implants. Clin Oral Implants Res. 1991;2: 1-19.
16. Lekholm UGJ, Henry P, Higuchi K, et al. Survival of the Brånemark implant in partially edentulous jaws: A 0-10 year prospective multicenter study. Int J Oral Maxillofac Implants. 1999;14:636-645.
17. Esposito M, Hirsch JM, Lekholm U, et al. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci. 1998;106:527-551.
18. Ekfeldt A, Christiansson U, Eriksson T, et al. A retrospective analysis of factors associated with multiple implant failures in maxillae. Clin Oral Implants Res. 2001;12:462-467.
19. Weyant RJ, Burt BA. An assessment of survival rates and within-patient clustering of failures for endosseous oral implants. J Dent Res. 1993;72:2-8.
20. Hutton JE, Heath MR, Chai JY, et al. Factors related to success and failure rates at 3-year follow-up in a multicenter study of overdentures supported by Brånemark implants. Int J Oral Maxillofac Implants. 1995;10:33-42.
21. Santos MCLG, Campos MIG, Line SRP. Early dental implant failure: A review of the literature. Braz J Oral Sci. 2002; 1: 103-111.
22. Thompson MW, McInnes RR, Willard HF. In: Thompson and Thompson Genetics in Medicine. 6th ed. Genes in Population. Philadelphia, PA: WB Saunders Company; 2001 : pp 540.
23. John S, Turner D, Donn R, et al. Two novel biallelic polymorphism in the IL-2 gene. Eur J Immunogenet. 1998;25: 419-420.
24. Olomolaiye O, Wood NA, Bidwell JL A novel Nlalll polymorphism in the human IL-6 promoter. Eur J of Immunogenet. 25(2-3):267, 1998.
25. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102: 1369-1376.
26. Pola R, Flex A, Gaetani E, et al. The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population. J Hum Hypertens. 2002;16:637-640.
27. Jahromi MM, Mill ward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res. 2000;20:885-888.
28. Revilla M, Obach V, Cervera A, et al. -174G/C polymorphism of the interleukin-6 gene in patients with Iacunar infarction. Neurosci Lett. 2002;324: 29-32.
29. McFarlane CG, Meikle MC. interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease. J Periodontol Res. 1991;26:402-408.
30. Scarel-Caminaga RM, Trevilatto PC, Souza AP, et al. Investigation of an IL-2 polymorphism in patients with different levels of chronic periodontitis. J Clin Periodontol. 2002;29:587-591.
31. Trevilatto PC, Scarel-Caminaga RM, Brito RB Jr, et al. Polymorphism at position -174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian population. J Clin Periodontol. 2003;30:438-442.
32. Trevilatto PC, Line SRP. Use of buccal epithelial cells for PCR amplification of large DMA fragments. J Forensic Odontostomatol. 2000;18:6-9.
33. Maniatis T, Fritsch EF, Sambrook J. In: Molecular Cloning: A Laboratory Manual. 2nd ed. Appendix E: Commonly Used Techniques in Molecular Cloning. New York, NY: Cold Spring Harbor Laboratory Press; 1989:458-463.
34. Sanguinetti CJ, Dias EN, Simpson AJG. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques. 1994;17:915919.
35. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995;59:97-105.
36. Esposito M, Hirsch JM, Lekholmll, et al. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci. 1998; 106:721-764.
37. Deas DE, Mikotowicz JJ, Mackey SA, et al. Implant failure with spontaneous rapid exfoliation: Case reports. Implant Dent. 2002;11:235-242.
38. Pietruski JK, Pietruska MD, Stokowska W, et al. Serum levels of interleukin-1 (IL-1), interleukin-6 (IL-6) and interleukin-8 (IL-8) in patients treated with dental implants. Rocz Akad Med Bialymst. 2001;46:28-37.
39. Kao RT, Curtis DA, Richards DW, et al. Increased interleukin-1 beta in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants. 1995;10:696701.
40. Panagakos FS, Aboyoussef H, Dondero R, et al. Detection and measurement of inflammatory cytokines in implant crevicular fluid: A pilot study. Int J Oral Maxillofac Implants. 1996;11:794799.
41. Salcetti JM, Moriarty JD, Cooper LF, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants. 1997; 12:32-42.
42. Aboyoussef H, Carter C, Jandinski JJ, etal. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants. 1998:13:689-696.
43. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol. 1999;70:724-729.
44. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997:24:72-77.
45. Rogers MA, Figliomeni L, Baluchova K, et al. Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodontol. 2002:37:37-41.
46. Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implants Res. 2003; 14:10-17.
47. Shimpuku H, Nosaka Y, Kawamura T, et al. Bone morphogenetic protein-4 gene polymorphism and early marginal bone loss around endosseous implants. Int J Oral Maxillofac Implants. 2003a;18:500-504.
48. Shimpuku H, Nosaka Y, Kawamura T, et al. Genetic polymorphisms of the interleukin-1 gene and early marginal bone loss around endosseous dental implants. Clin Oral Implants Res. 2003b;14:423-429.
49. Santos MCLG, Campos MIG, Souza AP, et al. Analysis of MMP-1 and MMP-9 promoter polymorphism in early osseointegrated implant failure. Int J Oral Maxillofac Implants. 2004;19:38-43.
50. Campos MIG, Santos MCLG, Trevilatto PC, et al. Early failure of dental implants and TNF- (G-308A) gene polymorphism. Implant Dent. 2004;13: 95-99.
51. Santos MCLG, Campos MIG, Souza AP, et al. Analysis of the transforming growth factor-fr gene promoter polymorphisms in early osseointegrated implant failure. Implant Dent. 2004;13: 262-269.
52. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:1813818144.
53. Cox ED, Hoffmann SC, DIMercurio BS, et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation. 2001;72:720-726.
54. Vozarova B, Fernandez-Real JM, Knowler WC, et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet. 2003;112:409-413.
55. Pola R, Flex A, Gaetani E, et al. The -74 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population. Neuroreport. 2002; 13:1645-1647.
56. Scarel-Caminaga RM, Trevilatto PC, Souza AP, et al. Frequencies of the -330 (T -> G) IL-2 and -590 (T -> C) IL-4 gene polymorphisms in a population from south-eastern Brazil. Eur J Immunogenet. 2002;29:293-296.
57. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet. 2000;27:241-249.
58. Perala DG, Chapman RJ, Gelfand JA, et al. Relative production of IL-1 beta and TNF alpha by mononuclear cells after exposure to dental implants. J Periodontol. 1992:63:426-430.
59. Wang JY, Tsukayama DT, Wicklund BH, et al. Inhibition of T and B cell proliferation by titanium, cobalt, and chromium: Role of IL-2 and IL-6. J Biomed Mater Res. 1996;32:655-661.
60. Nakashima Y, Sun DH, Trindade MC, et al. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg. 1999;81:603-615.
61. Shida J, Trindade MC, Goodman SB, et al. Induction of interleukin-6 release in human osteoblast-like cells exposed to titanium particles in vitro. Calcif Tissue Int. 2000;67:151-155.
62. Horowitz SM, Gonzales JB. Inflammatory response to implant particulates in a macrophage/osteoblast coculture model. Calcif Tissue Int. 1996;59:392-396.